United States Federal Circuit

Summary judgment for defendant in a patent infringement action involving a pharmaceutical to treat rheumatoid arthritis is affirmed where plaintiff lacked standing to bring the suit because it did not have sole ownership of the patent.

Appellate Information

• Decided 01/29/2007
• Published 01/29/2007

Judges

• SARIS, District Judge., Before BRYSON, PROST, Circuit Judges, and SARIS, District Judge.

Court

• United States Federal Circuit

Counsel

• For Appellant:
  
• Thomas L. Hamlin, Robins, Kaplan, Miller & Ciresi L.L.P, of Minneapolis, MN, argued for plaintiff-appellant Israel Bio-Engineering Project.   With him on the brief were Stephen P. Safranski, Brian A. Mayer, and Ross A. Abbey.


• For Appellees:
  
• Barbara R. Rudolph, Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P, of Washington, D.C., argued for defendants-appellees Amgen Inc., et al.   With her on the brief were Gerald F. Ivey and William L. Strauss.   Of counsel on the brief were Stuart L. Watt, Monique L. Cordray, Karen L. Nicastro, Kathleen Fowler, and Gail Katz, Amgen Inc., of Thousand Oaks, CA;  Vicki G. Norton, Wilson Sonsini Goodrich & Rosati, P.C., of San Diego, CA;  and Nicole W. Stafford, Wilson Sonsini Goodrich & Rosati, P.C., of Austin, TX., Nicholas Groombridge, Weil, Gotshal & Manges LLP, of New York, N.Y. argued for defendant-appellee Yeda Research and Development Co., Ltd. With him on the brief were Michael Eisenberg, Daniel J. Melman, and Peter Sandel.   Of counsel was John D. Garretson, Fish & Richardson, P.C. of New York, NY., Wayne M. Barsky, Gibson, Dunn & Crutcher LLP, for defendants-appellees Inter-Lab Ltd., et al of Los Angeles, CA.